5PSQ-046 Direct-acting antivirals for hepatitis c virus in hiv co-infected patients

BACKGROUND: The development of new direct acting antivirals (DAAs) for hepatitis C virus (HCV) represents an evolution in the treatment. As HIV-HCV coinfection is common, evaluation of DAAs’ effectiveness and drug interactions with antiretroviral therapy (ART) is useful in this population. PURPOSE:...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur J Hosp Pharm
Prif Awduron: Rey, MB Contreras, Gutiérrez, J Estaire, del Moral, R Sánchez, Alonso, MM Romero, Raya, MA Bolivar, Martín, C Bocanegra
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Group 2018
Pynciau:
Section 5: Patient safety and quality assurance
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535170/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.400
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg